EATG » Women

Women

Injectable hormonal contraceptive does not raise HIV risk, large trial finds

A large trial has found no difference in the risk of acquiring HIV for women using three different types of long-acting, reversible contraception in sub-Saharan Africa. Findings from the ECHO…

South Africa: Alarming HIV infection rate

Statistics show 1200 girls between the ages of 15 and 24 are infected with HIV every week in South Africa. According to the Higher Education and Training HIV/Aids Programme (HEAIDS),…

Women who inject drugs more likely to be living with HIV

Drug use is more common among men, with women accounting for just one in three people who use drugs and one in five people who inject drugs. However, women who…

Global Fund posts discuss efforts to support young women, girls to end HIV/AIDS

Global Fund to Fight AIDS, Tuberculosis and Malaria’s “VOICES”: Silence Is Bad for Women’s Health Linda Mafu, head of political and civil society advocacy at the Global Fund, discusses the…

Young women demand accountability at Women Deliver

It has been 25 years since the groundbreaking International Conference on Population and Development, held in Cairo, Egypt, in 1994. Since then, significant progress has been made in the area of…

PEPFAR will invest nearly $2 billion this year to empower and support women and girls

This comprehensive commitment will reach millions of women and girls, advance gender equality, and yield lifesaving results. Vancouver, British Columbia (June 4, 2019) – At the Women Deliver Conference in Vancouver,…

‘Killing my Own Baby’: Challenges faced by breastfeeding mothers with HIV

Prevention-of-mother-to-child-transmission programs aim to reduce the rate of babies born infected with HIV by treating women during pregnancy and the breastfeeding period. These programs are very effective when followed, but…

Focus on ending HIV among adolescent girls and young women

Despite great progress made against HIV globally, adolescent girls and young women continue to be disproportionately at risk of new HIV infections. In sub-Saharan Africa, twice as many girls and…

Johnson & Johnson announces full enrollment in proof-of-concept efficacy study of Janssen’s investigational HIV preventive vaccine

Phase 2b efficacy study of mosaic-based vaccine successfully enrolls 2,600 women aged 18-35 across five southern African countries NEW BRUNSWICK, NJ, May 29, 2019 – Johnson & Johnson today announced that…

Half of HIV patients are women. Most research subjects are men.

Trials of vaccines and treatments have not included enough female participants. Now that scientists are exploring possible cures, the need to enroll women is greater than ever. Inspired by reports of…

1 2 3 38